|
|
|
|
(1) Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (2) 2007 addendum.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2001 Jan (revised 2006 Nov; addendum released 2007 Sep).
64 pages.
NGC:005956
|
|
|
|
|
Abatacept for the treatment of rheumatoid arthritis.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2008 Apr.
29 pages.
NGC:006483
|
|
|
|
|
Acutely ill patients in hospital: recognition of and response to acute illness in adults in hospital.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2007 Jul.
106 pages.
NGC:005850
|
|
|
|
|
Adalimumab for the treatment of adults with psoriasis.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2008 Jun.
25 pages.
NGC:006624
|
|
|
|
|
Adalimumab for the treatment of psoriatic arthritis.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2007 Aug.
26 pages.
NGC:005900
|
|
|
|
|
Adalimumab, etanercept and infliximab for ankylosing spondylitis.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2008 May.
47 pages.
NGC:006523
|
|
|
|
|
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2006 Feb.
37 pages.
NGC:004902
|
|
|
|
|
Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2008 Oct.
62 pages.
NGC:006953
|
|
|
|
|
Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2005 Jan (revised 2008 Oct).
67 pages.
NGC:006955
|
|
|
|
|
Alteplase for the treatment of acute ischaemic stroke.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2007 Jun.
22 pages.
NGC:005742
|
|
|
|
|
Anaemia management in chronic kidney disease. A national clinical guideline for management in adults and children.
National Collaborating Centre for Chronic Conditions - National Government Agency [Non-U.S.].
2006.
172 pages.
NGC:005249
|
|
|
|
|
Atrial fibrillation. National clinical guideline for management in primary and secondary care.
National Collaborating Centre for Chronic Conditions - National Government Agency [Non-U.S.].
2006.
173 pages.
NGC:005149
|
|
|
|
|
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2007 Jan.
34 pages.
NGC:005509
|
|
|
|
|
Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care.
National Collaborating Centre for Mental Health - National Government Agency [Non-U.S.].
2003 Sep (revised 2006 Nov).
592 pages.
NGC:005729
|
|
|
|
|
Brief interventions and referral for smoking cessation in primary care and other settings.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2006 Mar.
36 pages.
NGC:005214
|
|
|
|
|
Caesarean section.
National Collaborating Centre for Women's and Children's Health - National Government Agency [Non-U.S.].
2004 Apr.
38 pages.
NGC:003544
|
|
|
|
|
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes’ C) colon cancer.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2006 Apr.
34 pages.
NGC:005415
|
|
|
|
|
Cardiac resynchronisation therapy for the treatment of heart failure.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2007 May.
28 pages.
NGC:005668
|
|
|
|
|
Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2007 Jun.
45 pages.
NGC:005735
|
|
|
|
|
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck.
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].
2008 Jun.
23 pages.
NGC:006625
|
|
|
